子宫腺肌症治疗课件_第1页
子宫腺肌症治疗课件_第2页
子宫腺肌症治疗课件_第3页
子宫腺肌症治疗课件_第4页
子宫腺肌症治疗课件_第5页
已阅读5页,还剩27页未读, 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

湖北省妇幼保健院Maternityandchildcarecentersinhubeiprovince王燕WangYanprojectdate

20/09/2007高强度聚焦超声治疗子宫腺肌症的临床研究TheClinicalStudyOfUltrasound-guidedHigh-intensityFocusedUltrasoundAblationForAdenomyosis湖北省妇幼保健院projectdate20/09/2001概念onception

02子宫腺肌病(adenomyosis,AM)一种常见妇科疾病,多发生在30-50岁经产妇。本病的发病机制尚不清楚AdenomyosisisacommonGynecologicaldiseasethatusuallyaffectmultiparasof30-to-50year-olds.Thepathogenesisofthisdiseaseisnotclear

现状:发病率升高,发病年龄呈下降趋势,对患者生活质量的影响也越来越大Thecurrentsituation:Theincidenceratesrisedwhiletheageofonsetdeclined,theinfluenceonthequalityoflifeofpatientsaregettingmoreandmoreserious概念onception02子宫腺肌病(adenomyos2文献资料:literature&information:可能与人工流产、宫内放置节育器、输卵管结扎、诊断性刮宫、分娩等因素相关——常损伤子宫内膜及浅肌层,导致基底层子宫内膜侵入子宫肌层内生长

Adenomyosismayberelatedtothefactorsofinducedabortion、IUD、tuballigation、curettage、childbirth,etc--whichusuallydamagetheendometriumandshallowmyometrium,causedthebasallayerofendometriuminvadeintomyometrium文献资料:3观察

observation手术治疗

surgery药物治疗

drugs治疗therapy

症状Symptoms年龄

Age生育要求Desireoffertility,观察治疗therapy症状4根治性手术Radicalsurgery子宫+双附件切除术Hysterectomyandbilateralsalpingo-oophorectomy(BSO)手术治疗surgicaltreatment

保守性手术:Conservativeoperation子宫内膜去除术(Transcervicalesectionofendometrium,TCRE)介入(UterineArterialEmbolization,UAE)腹腔镜子宫动脉结扎术(LaparoscopicUterineArteryLigation,LBUAB)超声聚焦治疗(HighIntensityFocusedUltrasound,HIFU)电消融治疗electricalablation子宫腺肌瘤挖除术myomectomyforuterinemyoma+腹腔镜子宫动脉阻断术(Laparoscopicuterinearteryblockage,LBUAB)+腹腔镜子宫神经去除术(Laparoscopyuterinenerveablation,LUNA)根治性手术手术治疗surgicaltreatment保守5根治性手术:1%Radicalsurgery保守性手术:80-95%

Conservativeoperation治疗方式的选择Thechoiceoftreatments根治性手术:1%治疗方式的选择6手术治疗的不足之处thedefectsofsurgicaltreatment不能处理微小病灶——复发Can'tdealwiththesmalllesions-Relapse不能去除病因——复发Havebeenunabletoremovethecauses-Relapse增加患者的压力和负担Increasingthepressureandburdenofpatients手术治疗的不足之处不能处理微小病灶——复发增加患者的压力和7保留子宫Preservationoftheuterus非侵入性Non-invasive不需麻醉Noanesthesia并发症、副作用少Therewerefewsideeffectsandcomplications保留生育功能Conservefertility可重复性好Wellrepeatability理想治疗方式Theidealtreatmants保留子宫Preservationoftheuterus8研究方法Researchmethods研究方法9HighIntensityFocusedUltrasoundAblationbyHaifu'sModelJC200skinHighIntensityFocusedUltraso10非月经期、非妊娠期、非哺乳期Non-menstrual,un-pregnant,nonpuerperalwomen.经妇检和B超确定为子宫腺肌病患者GynecologicalexaminationandType-Bultrasonicscanevidenceoftypicalfeaturesofadenomyosis.所有病例均有渐进性痛经、经量增多、经期延长以及下腹部坠胀、腰酸、腹痛等症状Allthecaseswiththeclinicalsymptomsofprogressivedysmenorrhea,menorrhagia,menostaxis,nextabdominalpainandswelling,lumbaracid,abdominalpain.无实施镇静镇痛的禁忌证,治疗前均签署知情同意书同意超声消融治疗Withoutthecontraindicationstosedativeandanalgesic,signaconsentformbeforetreatment.病例选择caseselection非月经期、非妊娠期、非哺乳期病例选择11下腹部瘢痕致明显声衰减或有放射治疗病史Theabdomenscarledtoobviousacousticattenuationorreceivedradiationtreatment.急性感染性疾病未控制、慢性盆腔感染至盆腔器官Uncontrolledacuteinfectivedisease,thechronicpelvicinfectiontopelvicorgans.下腹部多次大手术、严重粘连者Reccivedrepeatedlyabdominamajorsurgerywithseriouslyadhesions.盆腔内有金属植入物Therearemetalimplantsinpelvic.严重心肺疾病史及患者不能俯卧2h者Withhistoryofseriouslypriorheartandlungdisease,inabilitytolieinapronepositionfor2hours.合并子宫外脏器内膜异位者未纳入本研究Withtheinternalorgansoftheuterusendometriosis.病例排除标准Excludingcriterion下腹部瘢痕致明显声衰减或有放射治疗病史病例排除标准12Patientdata:Characteristics

病例基本资料Cases病例数40Age(median):yearsold年龄:(岁)27-49(37.9)Number(Uterinemyoma+adenomyosis)病灶数(子宫腺肌瘤+子宫腺肌病)37Number(adenomyosis)病灶数(子宫腺肌病)3Anterior/Posterior/Both前壁/后壁/前后壁11/15/14Maximaldia.(mean)最大径(厘米)2.5-8.4cmPatientdata:Characteristics

病13Patientdata:accompanyingsymptoms

患者资料:伴随症状Case病例数40Withsymptoms(%)出现症状率100%Lowerabdominalswellingpain下腹部胀痛88%Increasedmenses月经量增多91%Disorderofmenstualcycle月经周期紊乱95%Painatlumbosacralportionduringtheperiod经期腰骶部疼痛89%Patientdata:accompanyingsymp14预处理:皮肤脱脂、脱气,膀胱及肠道准备pretreatment:degreasing,degassing,intestinalandbladderpreparation镇静镇痛方案:芬太尼、咪唑安定Sedationandanalgesia:midazolam,fentanyl.治疗前、后超声造影Receivecontrast-enhancedultrasoundbeforeandaftertreatment.

治疗方法therapeuticmethod预处理:皮肤脱脂、脱气,膀胱及肠道准备治疗方法15治疗参数TreatmentparameterFrequency频率:1MHzFocallength焦距:134mmDiameteroftrasnducer治疗头直径:220mmScanningmode扫描模式:singleexposure点扫描Thickness层面距离:4-5mmStartingpower开始功率:250w-300wMaximalpower最大功率:400w治疗参数Frequency频率:1MHz16评估方法Methodsofevaluation:超声造影contrast-enhancedultrasound

彩色超声定期随访检查(治疗后1、3、6个月)Regularfollow-upbyColorDopplerSonography(aftertreatment1month,3month,6month)

临床症状评分theclinicalsymptomgrades评估内容evaluatingcontent:消融定量评估quantitativeablationevaluation

腺肌瘤及子宫消融前后声像图变化comparedthechangingoftheacousticimageofuterusandendometriomabeforeandaftertreatment.

临床症状改善theimprovementofsymptoms腺肌病消融后的疗效评估内容Theevaluationsofefficacyafter评估方法Methodsofevaluation:腺肌病17应用超声造影计算腺肌病的消融疗效computietheeffectiveinablatingbycontrast-enhancedultrasound

病例插图1The1thillustrationofcases

腺肌瘤体积(FV)=消融体积(NPV)=体积消融比率=NPV/FV×100%=应用超声造影计算腺肌病的消融疗效病例插图1腺肌瘤体积(FV18应用超声造影计算腺肌病的消融疗效computietheeffectiveinablatingbycontrast-enhancedultrasound病例插图2The2thillustrationofcases腺肌瘤体积(FV)=消融体积(NPV)=体积消融比率=NPV/FV×100%=应用超声造影计算腺肌病的消融疗效病例插图2腺肌瘤体积(FV)19应用超声造影计算腺肌病的消融疗效computietheeffectiveinablatingbycontrast-enhancedultrasound病例插图3The3thillustrationofcases腺肌瘤体积(FV)=消融体积(NPV)=体积消融比率=NPV/FV×100%=应用超声造影计算腺肌病的消融疗效病例插图3腺肌瘤体积(FV)20治疗前后各指标变化情况

Thechangeofindexsbeforeandaftertreatment结果results治疗前后各指标变化情况

Thechangeofin21在40例腺肌病患者中,32例(80%)治疗后即刻出现团块状灰度变化,5例(12.5%)出现整体灰度变化,3例(7.5%)治疗中未观察到灰度变化Inthe40caseofadenomysis,thereare32cases(80%)appearedlumpishgrayscalechangeimmediatelyaftertreatment,32cases(80%)appearedlumpishlumpishchangeimmediatelyaftertreatment,5cases(12.5%)appearedholisticgrayscalechangeimmediatelyaftertreatment,treatment,3cases(7.5%)didnotappearegrayscalechangeimmediatelyaftertreatment.治疗后变化Thechangeaftertreatment在40例腺肌病患者中,32例(80%)治疗后即刻出现团块状22治疗前后超声造影检查腺肌瘤灭活部分造影剂充盈缺损,呈无回声 Thecontrast-enhancedultrasoundaftertreatmentshowthatnocontrastmediumandhyperechoicin

nactivatedadenomysis每个腺肌病均有不同程度的灭活,灭活率为20%~95%,平均75%左右,其中灭活率90.0%以上的腺肌瘤占37.5%(15/40),灭活率75.0%以上的腺肌病占70%(28/40)Alltheadenoymisistherewerecertaindegreeofinactivation,thedeactivation–rateis20%-95%,theaveragedeactivation–rateabout75%,thecasesofrategreaterthan90.0%accountsfor37.5%(15/40),thecasesofrategreaterthan75.0%accountsfor70%(28/40),治疗后变化Thechangeaftertreatment治疗前后超声造影检查腺肌瘤灭活部分造影剂充盈缺损,呈无回声治23月经量增多改善theimprovementofmenstruation临床症状改善clinicallyimprovementinsymptoms随访时间follow-uptime显效obviouseffects(%)有效effective(%)无效invalid(%)术后1月after1month3(7.5)28(70)9(22.5)术后3月after3month8(20)30(75)2(5)术后6月after6month9(22.5)29(72.5)2(5)月经量增多改善theimprovementofmen24痛经症状改善theimprovementofdysmenorrhea临床症状改善clinicallyimprovementinsymptoms随访时间follow-uptime显效(%)有效(%)无效(%)术后1月after1month6(15)30(75)4(10)术后3月after3month18(45)21(52.5)1(2.5)术后6月after6month21(52.5)17(42.5)2(5)痛经症状改善theimprovementofdysme25HIFU治疗后行彩超随访,39例患者治疗中均可见腺肌瘤区域内回声增强,部分出现小的团状强回声Thefollow-upafterHIFUtreatmentshowthatthere39patientsthetreatareaechoesofhighamplitude,someoneappearstrongecho.影像学随访follow-upofImagingHIFU治疗后行彩超随访,39例患者治疗中均可见腺肌瘤区域内26治疗1个月:腺肌瘤体积无明显变化,3例体积略增大,瘤体内回声较前增强、不均,边界逐渐模糊,血流信号明显减少(8例开始出现坏死液化)aftertreatment1month:therearenotsignificantchangeofUterinemyomavolume,3cases'volumeincreased,theechoofmyomaenhancedandunevenness.thebordersareblurringgradually,thebloodflowsignalssignificantlydecreased(Ofthe8patientswithliquefactionnecrosis)治疗3个月~6个月:腺肌瘤体积逐渐缩小;血流信号稀少或未见血流信号,瘤体周边见较细的血流信号存在aftertreatment1-3month:Uterinemyomavolumedecreasedgradually;therearefewornobloodflowsignals,therearesomesmallerbloodflowsignalspara-tumors.影像学随访follow-upofImaging治疗1个月:腺肌瘤体积无明显变化,3例体积略增大,瘤体内回声27HIFU治疗子宫腺肌病的安全性ThesafetyofHIFUablaeadenomyosis治疗中Durningthetreatment:

疼痛(盆腔内治疗区、骶尾部、会阴、下肢,疼痛评分2-3分,患者均诉可耐受)pain(treatmentareasinpelviccavity,Sacrococcygealregion,perineum,legs,painscorewas2-3points,allthepatientscouldtolerance.)皮肤灼伤:未见SkinBurns:noHIFU治疗子宫腺肌病的安全性治疗中Durningthe28治疗后aftertreatment:

骶尾部胀痛2例(治疗次日既缓解)Sacrococcygealregionpain2case(disapperdnextday)治疗区皮肤压痛3例(2-4天即缓解)pressingpainoftheskinoftreatmentarea(disapperdin2-4days)

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

最新文档

评论

0/150

提交评论